Profile data is unavailable for this security.
About the company
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.
- Revenue in USD (TTM)10.14m
- Net income in USD-38.32m
- Incorporated2013
- Employees49.00
- LocationJaguar Health Inc200 PINE STREET SUITE 400SAN FRANCISCO 94104United StatesUSA
- Phone+1 (415) 371-8300
- Fax+1 (302) 655-5049
- Websitehttps://jaguar.health/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. | 65.00k | -5.95m | 23.00m | 4.00 | -- | 3.38 | -- | 353.88 | -0.8903 | -0.8903 | 0.0097 | 0.8667 | 0.0094 | -- | -- | 16,250.00 | -85.49 | -- | -103.85 | -- | 92.00 | -- | -9,129.42 | -- | -- | -278.20 | 0.0694 | -- | 550.00 | -- | -91.11 | -- | -- | -- |
| Iterum Therapeutics PLC | 0.00 | -35.58m | 23.01m | 14.00 | -- | -- | -- | -- | -2.64 | -2.64 | 0.00 | -0.3734 | 0.00 | -- | -- | 0.00 | -91.54 | -118.12 | -136.45 | -199.23 | -- | -- | -- | -890,554.10 | -- | -- | 1.44 | -- | -- | -- | 13.64 | -- | -32.09 | -- |
| Bioxytran Inc | 0.00 | -4.30m | 23.27m | 2.00 | -- | -- | -- | -- | -0.0297 | -0.0297 | 0.00 | -0.0017 | 0.00 | -- | -- | -- | -2,431.80 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -7.69 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| Qilian International Holding Group Ltd | 46.47m | -7.78m | 23.59m | 298.00 | -- | 0.5513 | -- | 0.5077 | -0.2176 | -0.2176 | 1.30 | 1.20 | 0.8027 | 6.45 | 33.30 | 155,944.60 | -14.03 | 2.71 | -16.84 | 3.86 | 3.77 | 11.66 | -17.48 | 2.72 | 4.43 | -0.4812 | 0.0107 | 26.11 | -28.35 | -1.60 | -822.64 | -- | 12.86 | -- |
| Apollomics Inc | 0.00 | -388.09m | 23.72m | -- | -- | 0.4257 | -- | -- | -4.34 | -4.34 | 0.00 | 0.6225 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1,391.69 | 0.012 | -- | -- | -- | -154.03 | -- | -- | -- |
| SAB Biotherapeutics Inc | 2.24m | -42.19m | 23.89m | 57.00 | -- | 0.417 | -- | 10.67 | -7.18 | -7.18 | 0.4056 | 6.21 | 0.0332 | -- | 0.8059 | 39,280.53 | -62.58 | -- | -77.39 | -- | -- | -- | -1,884.50 | -- | -- | -- | 0.0743 | -- | -90.63 | -- | -125.14 | -- | -- | -- |
| Biomx Inc | 0.00 | -26.17m | 24.07m | 58.00 | -- | 5.15 | -- | -- | -0.5433 | -0.5433 | 0.00 | 0.067 | 0.00 | -- | -- | 0.00 | -74.18 | -- | -101.74 | -- | -- | -- | -- | -- | -- | -21.95 | 0.7841 | -- | -- | -- | 7.59 | -- | -- | -- |
| TherapeuticsMD Inc | 1.20m | -6.20m | 24.33m | 1.00 | -- | 0.8489 | -- | 20.29 | -0.58 | -0.6955 | 0.1103 | 2.49 | 0.0236 | -- | 0.4556 | 1,199,000.00 | -12.19 | -53.35 | -16.34 | -111.61 | 73.89 | 86.67 | -516.93 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Unity Biotechnology Inc | 0.00 | -34.78m | 24.51m | 19.00 | -- | 1.02 | -- | -- | -2.33 | -2.33 | 0.00 | 1.43 | 0.00 | -- | -- | 0.00 | -40.18 | -47.21 | -48.47 | -53.51 | -- | -- | -- | -6,395.92 | -- | -- | 0.00 | -- | -100.00 | -- | 10.36 | -- | -61.28 | -- |
| Acasti Pharma Inc | 0.00 | -38.77m | 24.91m | 32.00 | -- | 0.3851 | -- | -- | -5.06 | -5.06 | 0.00 | 6.88 | 0.00 | -- | -- | -- | -40.18 | -45.71 | -41.30 | -50.84 | -- | -- | -- | -69,798.47 | -- | -14.38 | 0.00 | -- | -- | -- | -332.11 | -- | -45.53 | -- |
| Jaguar Health Inc | 10.14m | -38.32m | 25.08m | 49.00 | -- | 1.95 | -- | 2.47 | -78.63 | -78.63 | 9.90 | 3.18 | 0.1806 | 0.2397 | 8.12 | 206,938.80 | -69.22 | -95.29 | -122.86 | -163.54 | 79.07 | 67.28 | -383.35 | -522.28 | 1.39 | -2.78 | 0.6919 | -- | -18.36 | 17.19 | 12.97 | -- | -- | -- |
| Lisata Therapeutics Inc | 0.00 | -20.05m | 26.33m | 25.00 | -- | 0.6125 | -- | -- | -2.46 | -2.46 | 0.00 | 5.18 | 0.00 | -- | -- | 0.00 | -35.01 | -45.97 | -38.40 | -50.47 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.57 | -- | -- | -- |
| NanoViricides Inc | 0.00 | -9.51m | 26.35m | 7.00 | -- | 2.47 | -- | -- | -0.8115 | -0.8115 | 0.00 | 0.9017 | 0.00 | -- | -- | 0.00 | -63.30 | -43.54 | -65.85 | -46.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.94 | -- | -8.90 | -- |
| Oncternal Therapeutics Inc | 1.15m | -36.38m | 26.93m | 27.00 | -- | 1.17 | -- | 23.40 | -12.35 | -12.35 | 0.3907 | 7.75 | 0.0263 | -- | -- | 42,629.63 | -83.23 | -49.40 | -95.97 | -54.51 | -- | -- | -3,160.73 | -1,342.98 | -- | -- | 0.00 | -- | -47.32 | -- | 10.62 | -- | -- | -- |
Data as of May 23 2024. Currency figures normalised to Jaguar Health Inc's reporting currency: US Dollar USD
2.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 2.60m | 0.94% |
| Commonwealth Equity Services LLCas of 31 Mar 2024 | 899.17k | 0.33% |
| Jane Street Capital LLCas of 31 Mar 2024 | 798.49k | 0.29% |
| XTX Markets LLCas of 31 Mar 2024 | 450.63k | 0.16% |
| BofA Securities, Inc.as of 31 Mar 2024 | 242.40k | 0.09% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 192.34k | 0.07% |
| G1 Execution Services LLCas of 31 Mar 2024 | 157.30k | 0.06% |
| Geode Capital Management LLCas of 31 Mar 2024 | 127.67k | 0.05% |
| Csenge Advisory Group LLCas of 31 Mar 2024 | 102.50k | 0.04% |
| Virtu Americas LLCas of 31 Dec 2023 | 100.68k | 0.04% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
